Perspectives of Academic Oncologists About Offering Expanded Access to Investigational Drugs
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.39766
Abstract: Key Points Question How do oncologists at large academic medical centers with experience pursuing expanded access (EA) to investigational medicines perceive this regulatory pathway and their role in it? Findings This qualitative study involved semistructured… read more here.
Keywords: academic oncologists; oncologists offering; expanded access; perspectives academic ... See more keywords
Barriers and facilitators to oncology clinical trial accrual: Comparing perceptions of community and academic oncologists.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e18131
Abstract: e18131 Background: Multiple studies have described the barriers and facilitators to oncology clinical trial accrual in academic practices. However, few studies have been done in community settings, even though the majority of patients with cancer… read more here.
Keywords: community; barriers facilitators; academic oncologists; oncology ... See more keywords